Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression

References

• Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C. 2015. Tumour necrosis factor-α inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res. 79:175–184.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2001. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (A Task Force Report of the American Psychiatric Association). 2nd ed. Washington (DC): American Psychiatric Association.
   Google Scholar
• Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG. 2010. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res. 44:321–330.
   PubMed Web of Science ®Google Scholar
• Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C. 1993. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol. 33:129–133.
   PubMed Web of Science ®Google Scholar
• Bromander S, Anckarsater R, Kristiansson M, Blennow K, Zetterberg H, Anckarsater H, Wass CE. 2012. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation. 9:242.
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 377:68–71.
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 3:791–800.
   PubMed Web of Science ®Google Scholar
• Conboy L, Varea E, Castro JE, Sakouhi-Ouertatani H, Calandra T, Lashuel HA, Sandi C. 2011. Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors. Mol Psychiatry. 16:533–547.
   PubMed Web of Science ®Google Scholar
• Dahl J, Ormstad H, Aass HC, Sandvik L, Malt UF, Andreassen OA. 2016. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand. 134:40–47.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 9:46–56.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry. 67:446–457.
   PubMed Web of Science ®Google Scholar
• Ellul P, Boyer L, Groc L, Leboyer M, Fond G. 2016. Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand. 134:469–484.
   PubMed Web of Science ®Google Scholar
• Engler H, Brendt P, Wischermann J, Wegner A, Rohling R, Schoemberg T, Meyer U, Gold R, Peters J, Benson S, et al. 2017. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms. Mol Psychiatry. Epub ahead of print. doi: 10.1038/mp.2016.264
   PubMed Web of Science ®Google Scholar
• Engler H, Doenlen R, Engler A, Riether C, Prager G, Niemi MB, Pacheco-Lopez G, Krugel U, Schedlowski M. 2011. Acute amygdaloid response to systemic inflammation. Brain Behav Immun. 25:1384–1392.
   PubMed Web of Science ®Google Scholar
• Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, et al. 2015. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 29:1063–1070.
   PubMed Web of Science ®Google Scholar
• Fosse R, Read J. 2013. Electroconvulsive treatment: hypotheses about mechanisms of action. Front Psychiatry. 4:94.
   PubMedGoogle Scholar
• Goldsmith DR, Rapaport MH, Miller BJ. 2016. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 21:1696–1709.
   PubMed Web of Science ®Google Scholar
• Haroon E, Miller AH, Sanacora G. 2017. Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology. 42:193–215.
   PubMed Web of Science ®Google Scholar
• Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P. 2003. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 19:183–188.
   PubMed Web of Science ®Google Scholar
• Hoyer C, Kranaster L, Janke C, Sartorius A. 2014. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 264:255–261.
   PubMed Web of Science ®Google Scholar
• Hoyo-Becerra C, Schlaak JF, Hermann DM. 2014. Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation. Brain Behav Immun. 42:222–231.
   PubMed Web of Science ®Google Scholar
• Inta D, Lima-Ojeda JM, Lau T, Tang W, Dormann C, Sprengel R, Schloss P, Sartorius A, Meyer-Lindenberg A, Gass P. 2013. Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS One. 8:e69869.
   PubMed Web of Science ®Google Scholar
• Jansson L, Orre K, Tingstrom A. 2012. Repeated electroconvulsive seizures increase the number of vessel-associated macrophages in rat hippocampus. J ECT. 28:174–179.
   PubMed Web of Science ®Google Scholar
• Jansson L, Wennstrom M, Johanson A, Tingstrom A. 2009. Glial cell activation in response to electroconvulsive seizures. Prog Neuropsychopharmacol Biol Psychiatry. 33:1119–1128.
   PubMed Web of Science ®Google Scholar
• Jarventausta K, Sorri A, Kampman O, Bjorkqvist M, Tuohimaa K, Hamalainen M, Moilanen E, Leinonen E, Peltola J, Lehtimaki K. 2017. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatr Scand. 135:87–92.
   PubMed Web of Science ®Google Scholar
• Jinno S, Kosaka T. 2008. Reduction of Iba1-expressing microglial process density in the hippocampus following electroconvulsive shock. Exp Neurol. 212:440–447.
   PubMed Web of Science ®Google Scholar
• Kathol RG, Jaeckle RS, Lopez JF, Meller WH. 1989. Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am J Psychiatry. 146:311–317.
   PubMed Web of Science ®Google Scholar
• Kern S, Skoog I, Borjesson-Hanson A, Blennow K, Zetterberg H, Ostling S, Kern J, Gudmundsson P, Marlow T, Rosengren L, et al. 2014. Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample. Brain Behav Immun. 41:55–58.
   PubMed Web of Science ®Google Scholar
• Kiecolt-Glaser JK, Derry HM, Fagundes CP. 2015. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 172:1075–1091.
   PubMed Web of Science ®Google Scholar
• Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. 2011. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 261:575–582.
   PubMed Web of Science ®Google Scholar
• Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, et al. 2013. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry. 18:93–100.
   PubMed Web of Science ®Google Scholar
• Lehtimaki K, Keranen T, Huuhka M, Palmio J, Hurme M, Leinonen E, Peltola J. 2008. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 24:88–91.
   PubMed Web of Science ®Google Scholar
• Maier B, Laurer HL, Rose S, Buurman WA, Marzi I. 2005. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J Neurotrauma. 22:822–835.
   PubMed Web of Science ®Google Scholar
• Martinez JM, Garakani A, Yehuda R, Gorman JM. 2012. Proinflammatory and ‘resiliency proteins in the CSF of patients with major depression’. Depress Anxiety. 29:32–38.
   PubMed Web of Science ®Google Scholar
• Matcham F, Rayner L, Steer S, Hotopf M. 2013. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 52:2136–2148.
   PubMed Web of Science ®Google Scholar
• Merighi S, Bencivenni S, Vincenzi F, Varani K, Borea PA, Gessi S. 2017. A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway. Pharmacol Res. 117:9–19.
   PubMed Web of Science ®Google Scholar
• Moon HY, Kim SH, Yang YR, Song P, Yu HS, Park HG, Hwang O, Lee-Kwon W, Seo JK, Hwang D, et al. 2012. Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc Natl Acad Sci USA. 109:13094–13099.
   PubMed Web of Science ®Google Scholar
• Muller N, Schwarz MJ. 2007. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry. 12:988–1000.
   PubMed Web of Science ®Google Scholar
• Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, et al. 2006. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 11:680–684.
   PubMed Web of Science ®Google Scholar
• Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, Arolt V, Muller N. 2011. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression–no influence of celecoxib treatment. J Affect Disord. 134:217–225.
   PubMed Web of Science ®Google Scholar
• Myint AM, Schwarz MJ, Muller N. 2012. The role of the kynurenine metabolism in major depression. J Neural Transm (Vienna). 119:245–251.
   PubMed Web of Science ®Google Scholar
• Nazimek K, Strobel S, Bryniarski P, Kozlowski M, Filipczak-Bryniarska I, Bryniarski K. 2017. The role of macrophages in anti-inflammatory activity of antidepressant drugs. Immunobiology. 222:823–830.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, DeCecco LM. 2001. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry. 62(Suppl 16):5–9.
   PubMed Web of Science ®Google Scholar
• O'Brien SM, Scott LV, Dinan TG. 2006. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 188:449–452.
   PubMed Web of Science ®Google Scholar
• Patas K, Penninx BW, Bus BA, Vogelzangs N, Molendijk ML, Elzinga BM, Bosker FJ, Oude Voshaar RC. 2014. Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features. Brain Behav Immun. 36:71–79.
   PubMed Web of Science ®Google Scholar
• Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. 2003. Major depression in multiple sclerosis: a population-based perspective. Neurology. 61:1524–1527.
   PubMed Web of Science ®Google Scholar
• Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. 2015. Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev. 57:30–45.
   PubMed Web of Science ®Google Scholar
• Prinz M, Priller J, Sisodia SS, Ransohoff RM. 2011. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci. 14:1227–1235.
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27:24–31.
   PubMed Web of Science ®Google Scholar
• Roman A, Nawrat D, Nalepa I. 2008. Chronic treatment with electroconvulsive shock may modulate the immune function of macrophages. J ECT. 24:260–267.
   PubMed Web of Science ®Google Scholar
• Rotheneichner P, Lange S, O'Sullivan A, Marschallinger J, Zaunmair P, Geretsegger C, Aigner L, Couillard-Despres S. 2014. Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast. 2014:723915.
   PubMedGoogle Scholar
• Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P. 2009. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry. 42:270–276.
   PubMed Web of Science ®Google Scholar
• Sasayama D, Hattori K, Wakabayashi C, Teraishi T, Hori H, Ota M, Yoshida S, Arima K, Higuchi T, Amano N, et al. 2013. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res. 47:401–406.
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. 2011. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888.
   PubMed Web of Science ®Google Scholar
• Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. 2005. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol. 160:204–209.
   PubMed Web of Science ®Google Scholar
• Smith RS. 1991. The macrophage theory of depression. Med Hypotheses. 35:298–306.
   PubMed Web of Science ®Google Scholar
• Stelzhammer V, Rothermundt M, Guest PC, Michael N, Sondermann C, Kluge W, Martins-de-Souza D, Rahmoune H, Bahn S. 2011. Proteomic changes induced by anaesthesia and muscle relaxant treatment prior to electroconvulsive therapy. Proteomics Clin Appl. 5:644–649.
   PubMed Web of Science ®Google Scholar
• Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ. 2015. Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol. 25:1532–1543.
   PubMed Web of Science ®Google Scholar
• Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 367:29–35.
   PubMed Web of Science ®Google Scholar
• van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC. 2015. Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? Transl Psychiatry. 5:e609.
   PubMed Web of Science ®Google Scholar
• Wang AK, Miller BJ. 2017. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. Epub ahead of print. doi: 10.1093/schbul/sbx035
   Web of Science ®Google Scholar
• Wennstrom M, Hellsten J, Ekdahl CT, Tingstrom A. 2003. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus. Biol Psychiatry. 54:1015–1024.
   PubMed Web of Science ®Google Scholar
• Wennstrom M, Hellsten J, Ekstrand J, Lindgren H, Tingstrom A. 2006. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry. 59:178–186.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Delpech JC. 2017. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences. Prog Neuropsychopharmacol Biol Psychiatry. 79:40–48.
   PubMed Web of Science ®Google Scholar
• Wohleb ES, Franklin T, Iwata M, Duman RS. 2017. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 17:497–511.
   Web of Science ®Google Scholar
• Yirmiya R, Rimmerman N, Reshef R. 2015. Depression as a microglial disease. Trends Neurosci. 38:637–658.
   PubMed Web of Science ®Google Scholar
• Zachrisson OC, Balldin J, Ekman R, Naesh O, Rosengren L, Agren H, Blennow K. 2000. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res. 96:157–165.
   PubMed Web of Science ®Google Scholar